Our Tests (original) (raw)
- Our Tests
- Clinical Science
- Resources
- About
- For Patients
- Newsroom
- Contact
Our Testskevin2023-02-18T12:16:09-05:00
OUR TESTS
The molecular profile to define and defeat her unique cancer.
What does genomic testing mean for you and your patients?
Prior to genomic profiling, treatment decisions were based solely on clinicopathologic factors – such as the patient’s age, tumor grade, lymph node involvement and hormone receptor status. While important to consider, they provide a more superficial view of your patient’s breast cancer.
At the genomic level, physicians can examine the activity of specific genes inside a tumor – how they interact to drive the behavior of a tumor. By pairing these insights with clinical factors, we can more comprehensively understand a woman’s unique cancer and more confidently plan her next steps.
What does genomic testing mean for you and your patients?
Prior to genomic profiling, treatment decisions were based solely on clinicopathologic factors – such as the patient’s age, tumor grade, lymph node involvement and hormone receptor status. While important to consider, they provide a more superficial view of your patient’s breast cancer.
At the genomic level, physicians can examine the activity of specific genes inside a tumor – how they interact to drive the behavior of a tumor. By pairing these insights with clinical factors, we can more comprehensively understand a woman’s unique cancer and more confidently plan her next steps.
Together, our tests address two critical questions.
With quick and precise answers, multidisciplinary care teams can better counsel patients on the best possible treatment options for their breast cancer. Choosing more effective treatment approaches can improve patient outcomes and quality of life while saving the healthcare system from unnecessary costs.
<6 day for results
from a core biopsy1,2
>95% success rate
for MammaPrint + BluePrint1
It’s nice to call the patient after the test and say, ‘The book is closed. You don’t need chemo.’
— Dr. Barry Rosen, MD
Timely clinical decisions.
With an accelerated turnaround time, our test results are ready as early as the initial surgery consultation. They allow you to build out a more complete treatment approach at the very start of patient discussions, helping to deepen patient trust and reduce second opinions.
The Treatment Timeline
1. McKelley, et al. SABCS 2020.
2. Agendia is committed to delivering results in less than 10 business days, and results are provided within 6 business days for the majority of cases.
I am so thankful that I had all the information I needed to make the right decision for me and my particular cancer.
— Sara, a breast cancer survivor
For the US, Puerto Rico, Canada
and South America
Agendia Inc. USA, 22 Morgan, Irvine, CA 92618
(888) 321-2732
customercare@agendia.com
**For outside the Americas
Agendia NV, Radarweg 60, 1043 NT Amsterdam, The Netherlands
+31 (0)20 462 1510
customerservice@agendia.com
©2024 Agendia. All rights reserved. MammaPrint and Blueprint are registered trademarks of Agendia, Inc.
Our Cookie Policy
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. See our Web Privacy Notice. By clicking “Accept”, you consent to the use of ALL cookies and clicking "Reject" means rejecting all except necessary cookies.
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Powered by 